Clinical Trial Update: Perifosine + Sunitinib Malate for Patients With Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating perifosine in combination with sunitinib malate for patients with advanced cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Renal Cell Carcinoma

Drugs mentioned

• Perifosine (perifosine)
• Sutent (sunitinib malate) (sunitinib malate)

Snippet

Sponsor: AEterna Zentaris | Conditions: Renal Cancer, GIST | Phase 1 | Status: COMPLETED